sulfamethoxazole has been researched along with Premature Birth in 1 studies
Sulfamethoxazole: A bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p208)
sulfamethoxazole : An isoxazole (1,2-oxazole) compound having a methyl substituent at the 5-position and a 4-aminobenzenesulfonamido group at the 3-position.
Premature Birth: CHILDBIRTH before 37 weeks of PREGNANCY (259 days from the first day of the mother's last menstrual period, or 245 days after FERTILIZATION).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, J | 1 |
| Ding, J | 1 |
| Di, X | 1 |
| Sun, W | 1 |
| Chen, H | 1 |
| Zhang, H | 1 |
1 other study available for sulfamethoxazole and Premature Birth
| Article | Year |
|---|---|
Association between prenatal antibiotics exposure and measures of fetal growth: A repeated-measure study.
Topics: Anti-Bacterial Agents; Birth Weight; Ciprofloxacin; Female; Fetal Development; Humans; Infant, Newbo | 2022 |